Global
Include All CSL Behring Country Sites
About CSL
Our Businesses
Our Products
Research and Development
Pandemic (H1N1) 2009
Business Development
Investors
Financial Reports
Briefings & Presentations
Annual General Meeting
Results Briefing
Operational Briefing
Performance Summary
Corporate Profile
Corporate Calendar
Dividends
Share registry
Archived ASX Releases
Newsroom
Careers
Contact CSL
|
CSL Websites
|
Site Map
|
Glossary
|
Home
> Investors
> Briefings & Presentations
> Operational Briefing
Operational Briefings
8 June 2010
Chief Operating Officer's Presentation
10 December 2009
R&D Briefing December 2009
(2.34Mb)
11 December 2008
R&D Briefing Dec 2008
(3.7Mb)
13 December 2007
R&D Briefing (PDF, 1.66MB)
14 December 2006
R&D Briefing (PDF, 1.21MB)
16 December 2005
R&D Briefing (PDF, 0.73MB)
16 December 2004
R&D Briefing (PDF, 1.03MB)
1 April 2004
CSL Completes Acquisition of Aventis Behring to create ZLB Behring
16 December 2003
R&D Briefing (PDF, 1.37MB)
10 December 2003
CSL Completes Institutional Equity Raising
Acquisition of Global Therapeutics Business of Aventis Behring (PDF, 4.18MB)
5 February 2003
CSL Managing Director's Presentation at the Merrill Lynch Healthcare Conference (PDF, 0.23MB)
13 December 2002
R&D Briefing (PDF, 1.03MB)
2001
Management Presentation - Acquisition of Nabi Plasma Collection Assets (PDF, 0.16MB)
© 2010 CSL Limited